Cataract News and Research

RSS
A cataract is a clouding of the lens in the eye that affects vision. Most cataracts are related to aging. Cataracts are very common in older people. By age 80, more than half of all Americans either have a cataract or have had cataract surgery.

A cataract can occur in either or both eyes. It cannot spread from one eye to the other.
Omeros launches OMIDRIAssure program to provide expanded patient access to Omidria

Omeros launches OMIDRIAssure program to provide expanded patient access to Omidria

ILUVIEN continues to show positive results in Europe

ILUVIEN continues to show positive results in Europe

Alimera Sciences announces results from ongoing study on ILUVIEN

Alimera Sciences announces results from ongoing study on ILUVIEN

UK’s GPs, optometrists confirm link between smoking and loss of vision

UK’s GPs, optometrists confirm link between smoking and loss of vision

IRIDEX launches novel intra-ocular pressure monitoring device

IRIDEX launches novel intra-ocular pressure monitoring device

Allergan enters into agreement to acquire Aquesys and its XEN45 program

Allergan enters into agreement to acquire Aquesys and its XEN45 program

Researchers find genetic cause of previously unknown disease

Researchers find genetic cause of previously unknown disease

Temporary postnatal visual deprivation induces permanent auditory responses in the brain's visual area

Temporary postnatal visual deprivation induces permanent auditory responses in the brain's visual area

Omeros reports additional positive data from OMS721 Phase 2 trial for treatment of thrombotic microangiopathies

Omeros reports additional positive data from OMS721 Phase 2 trial for treatment of thrombotic microangiopathies

Omeros plans to file patent infringement lawsuit against Par

Omeros plans to file patent infringement lawsuit against Par

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

Omeros receives EC approval to market Omidria in EU and other European countries

Omeros receives EC approval to market Omidria in EU and other European countries

Omeros' OMS721 granted FDA Fast Track designation for treatment of atypical hemolytic uremic syndrome

Omeros' OMS721 granted FDA Fast Track designation for treatment of atypical hemolytic uremic syndrome

New study suggests novel ways to treat serous retinal detachment

New study suggests novel ways to treat serous retinal detachment

Gene therapy provides life-long protection to photoreceptor cells in animal model of retinitis pigmentosa

Gene therapy provides life-long protection to photoreceptor cells in animal model of retinitis pigmentosa

Bayer Yakuhin receives MHLW approval in Japan for EYLEA (aflibercept) Injection to treat RVO patients

Bayer Yakuhin receives MHLW approval in Japan for EYLEA (aflibercept) Injection to treat RVO patients

University of Delaware researchers identify prime suspects in cataract formation

University of Delaware researchers identify prime suspects in cataract formation

Iowa's advanced driving simulator to help assess newly developed artificial lens for cataract patients

Iowa's advanced driving simulator to help assess newly developed artificial lens for cataract patients

Omeros signs exclusive license agreement with Fagron affiliates for commercialization of OMS103

Omeros signs exclusive license agreement with Fagron affiliates for commercialization of OMS103

FE65 and FE65L1 proteins may become therapeutic target for muscular dystrophy, cataracts and Alzheimer's

FE65 and FE65L1 proteins may become therapeutic target for muscular dystrophy, cataracts and Alzheimer's